Chief Physician and Head of the Interventional Cardiology Unit
at Morges EHC Hospital
Specialist in Cardiology and Interventional Cardiology, member of the FMH (Swiss Medical Association)
Clinique de Genolier
Route du Muids 3
1272 Genolier
Chief Physician and Head of the Interventional Cardiology Unit
at Morges EHC Hospital
Head of Clinic in the Interventional Cardiology Unit at the University Hospital Center of Vaud (CHUV).
CHUV.
Training in coronary angiography and cardiac imaging at the Interventional Cardiovascular Center (Melun) and Antony Private Hospital (Antony, France).
Contract Hospital Practitioner (PHc) in the coronary angiography department -
Functional Investigations – Henri Mondor University Hospital (Créteil, France). Coronary angiography activities
(coronary angioplasties, right KT, structural procedures: TAVI, FAG, FOP). Day hospital activities in
cardiology with development of outpatient activities. Fundamental research activities on
“hemorrhagic shock” – Mondor Institute for Biomedical Research (IMRB) - Inserm U955 Team 3
Cardiology Physician Assistant - Marie Madeleine Hospital (Forbach, France) with initial training in coronary angiography (Metz-Thionville Regional Hospital, France)
Cardiac Surgery Intensive Care Assistant (University Hospital of Trieste, Italy)
Interventional Cardiology Fellowship and Cardiac Imaging Fellowship (Paris, France).
Diploma in Cardiology - University of Trieste (Italy).
Cardiology Intern - Trieste University Hospital (Italy).
Internships in Cardiology, Infectious Diseases, and Internal Medicine (University Hospital
of Nice, France).
Degree in Medicine - Trieste University Hospital (Italy).
Internship in the Cardiology Department – Cotonou University Hospital (Benin).
Internship in the Internal Medicine Department - Lariboisière Hospital (Paris).
Internship in the Cardiology Department – Bellvitge University Hospital (Barcelona, Spain).
Principal investigator:
o TransRadIal Evaluation STudy of diamEter increase after vasodilatory drugs
administration. The TRIESTE randomized study
o KISS Study - Keep bIfurcation Single stenting Simple
o Bioflow DAPT - A Prospective, Randomized, Multi-center Study to Assess the SaFety of the
Orsiro Mission Stent compared to the ResoLute Onyx Stent in Subjects at High Risk for
Bleeding in combination With 1-month Dual Antiplatelet Therapy (DAPT)
Co-investigator:
- The Moca 1 study (CorFlow) - Microvascular Obstruction With CoFI™ System Assessment
- PACIFIC (Study to Gather Information About the Proper Dosing and Safety of the Oral FXIa Inhibitor
BAY 2433334 in Patients Following an Acute Heart Attack)
- POT-Puff (Evaluation of saline compared to media contrast for Optical Coherence Tomography).
- Biosolve IV (safety and performance of the Magmaris sirolimus-eluting bioresorbable magnesium
scaffold in a large patient population)
- ENVISAGE-TAVI AF Investigators. Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after
TAVR
- EuroPCR: regular participant and speaker.
- GRCI (Interventional Cardiology Think Tank): participant and speaker
- ESC (European Society of Cardiology) Congress: presentation of oral communications and posters
- SwissCTO: member of the scientific committee, live case commentary and moderation of
sessions on complex coronary angioplasties.
- Cardiofolies: member of the scientific committee and organization of the first edition (2026).